Regulatory developments

O Donnell, E, P 1982, Safely Goals and Risk Analysis Status of Regulatory Development, Joint ASME/ANS Nuclear Engineering Conference, July. 

In Figure 4.3, the major milestones in dmg regulatory development in the 10 countries are presented as a time-scale, to illustrate discrete development versus continuous development of dmg regulation. 

Since Professor Martel s book was first published, further regulatory developments worldwide have emphasised and reinforced the central role of hazard and risk... 

IMPACT OF REGULATORY DEVELOPMENTS ON THE DEMAND FOR BLOWING AGENTS IN FOAMS... 

As you can see, during the regulatory development of TSCA, the chemical industry has been alert to the practical impacts of the law and its ensuing regulations. Representatives of individual manufacturers, CMA and other trade associations, have participated at every opportunity to provide EPA with the factual data it requires and to show the practical implications of its proposals in order to prevent EPA from over-extending its power beyond its statutory authority. CMA has asked EPA to be more sensitive to the impact of these regulatory requirements on innovation and other economic aspects of this i ndus try. 

Each state has a professional pharmacy organization, some of which are affiliated with the American Pharmaceutical Association, Similarly, state organizations of hospital pharmacists exist in affiliation with the ASHP, Likewise, local or county associations exist in most instances. Each national association publishes a journal as do most state organizations, The FederalRegister reports proposed and enacted federal regulatory occurrences several times a week. Each stale has a similar publication to report its legislation and regulatory developments, e.g The Pennsylvania Bulletin. 

Testing volatile organic emissions to air from construction materials and consumer products used indoors is the subject of intensive standard method development at the current time. Most of the world s leading national and international standards agencies are involved to a greater or lesser extent. There are several reasons for this sudden burst of activity. Top of the list are recent regulatory developments such as ... 

Recent regulatory developments at state, national and international level suggest that certification of products, according to their emissions, is expected to become mandatory across much of the developed world for building materials and related products. This will affect both manufacturers and importers. 

This FDA Orphan-Drug Review checklist has been designed in consultation with FDA reviewers, industry consultants, and regulatory professionals to serve as a summary tool indicating the evaluative criteria used by the Office of Orphan-Drug Development to critique and assess applications received. It can be used internally as a part of the Quality Assurance process, as a guideline for regulatory development of an application, and/or as a self-assessment tool to predict likely FDA response to an application. 

The AcuSafe website provides a comprehensive electronic newsletter entitled AcuSafe News. Their newsletter is devoted to serving industry, government, and interested members of the public by providing process safety practices, incident news, lessons learned, and regulatory developments. Hazard View is a source of advice, comments, and information about major accident hazards in the process industries. It is for safety, environment, and risk professionals. Their View Library has a number of vivid images of the damages from accidents. [1]... 

I have characterized the scientific and technical components of the regulatory system as playing a secondary role in the regulatory development, because in fact they are not the driving force in development. Thus, it is entirely possible for the system to move forward in the face of partial scientific and technical input, or even, in the worst case, inadequate and unsatisfactory scientific and technical input and decisions. 

In this chapter, we will give an account of the issues at stake around regulatory expertise, as we encountered them in our Amsterdam discussions and how we saw possible futures at the time. Second, we want to compare our expectations to regulatory developments since, as reflected in this volume. Last, we will once again try to look forward and explore regulatory futures. 

Sesardic, D., and Dobbelaer, R. (2004), European union regulatory developments for new vaccine adjuvants and delivery systems, Vaccine, 22, 2452-2456. 

Keep the outsourcing company np to date with regulatory developments and comphance expectations (possibly condnct tailored training programs). 

---